Vitamin Shoppe Inc (VSI) Major Shareholder Buys $1,620,392.32 in Stock

Vitamin Shoppe Inc (NYSE:VSI) major shareholder Vintage Capital Management Llc acquired 326,692 shares of the stock in a transaction on Friday, January 5th. The stock was bought at an average price of $4.96 per share, for a total transaction of $1,620,392.32. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Vintage Capital Management Llc also recently made the following trade(s):

  • On Tuesday, January 2nd, Vintage Capital Management Llc acquired 133,804 shares of Vitamin Shoppe stock. The stock was bought at an average price of $4.28 per share, for a total transaction of $572,681.12.
  • On Saturday, December 29th, Vintage Capital Management Llc acquired 234,343 shares of Vitamin Shoppe stock. The stock was bought at an average price of $4.36 per share, for a total transaction of $1,021,735.48.

Vitamin Shoppe Inc (NYSE VSI) traded down $0.05 during trading on Monday, reaching $5.25. The company’s stock had a trading volume of 1,318,537 shares, compared to its average volume of 1,019,880. Vitamin Shoppe Inc has a 1-year low of $2.95 and a 1-year high of $23.85. The stock has a market cap of $125.88, a price-to-earnings ratio of -0.50 and a beta of 0.68. The company has a current ratio of 2.07, a quick ratio of 0.32 and a debt-to-equity ratio of 0.59.

Vitamin Shoppe (NYSE:VSI) last announced its earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.20). Vitamin Shoppe had a negative net margin of 20.27% and a positive return on equity of 6.17%. The business had revenue of $288.20 million for the quarter, compared to analysts’ expectations of $297.61 million. During the same quarter last year, the business earned $0.50 EPS. The company’s quarterly revenue was down 8.5% on a year-over-year basis. sell-side analysts forecast that Vitamin Shoppe Inc will post 0.34 earnings per share for the current fiscal year.

Several equities research analysts have commented on VSI shares. Zacks Investment Research upgraded Vitamin Shoppe from a “sell” rating to a “hold” rating in a research report on Wednesday, October 25th. ValuEngine upgraded Vitamin Shoppe from a “hold” rating to a “buy” rating in a research report on Thursday, October 5th. Morgan Stanley lowered their price objective on Vitamin Shoppe from $7.50 to $4.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 9th. Finally, Barclays lowered their price objective on Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 9th. Four analysts have rated the stock with a sell rating and five have issued a hold rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $5.00.

Several large investors have recently made changes to their positions in the company. Arizona State Retirement System lifted its position in shares of Vitamin Shoppe by 0.8% during the 2nd quarter. Arizona State Retirement System now owns 12,460 shares of the specialty retailer’s stock valued at $145,000 after buying an additional 100 shares in the last quarter. BNP Paribas Arbitrage SA lifted its position in shares of Vitamin Shoppe by 2.1% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock valued at $108,000 after buying an additional 192 shares in the last quarter. Martingale Asset Management L P lifted its position in shares of Vitamin Shoppe by 4.7% during the 2nd quarter. Martingale Asset Management L P now owns 27,008 shares of the specialty retailer’s stock valued at $315,000 after buying an additional 1,208 shares in the last quarter. Voya Investment Management LLC lifted its holdings in Vitamin Shoppe by 7.5% in the 2nd quarter. Voya Investment Management LLC now owns 34,810 shares of the specialty retailer’s stock valued at $406,000 after purchasing an additional 2,414 shares in the last quarter. Finally, Legal & General Group Plc lifted its holdings in Vitamin Shoppe by 9.3% in the 2nd quarter. Legal & General Group Plc now owns 44,555 shares of the specialty retailer’s stock valued at $518,000 after purchasing an additional 3,789 shares in the last quarter. Hedge funds and other institutional investors own 90.35% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This piece was posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece on another domain, it was stolen and reposted in violation of international trademark & copyright laws. The correct version of this piece can be viewed at https://www.com-unik.info/2018/01/08/vitamin-shoppe-inc-vsi-major-shareholder-buys-1620392-32-in-stock.html.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit